Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05824559
Title ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors MEI Pharma, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Southern California Los Angeles California 90033 United States Details
Mount Sinai Miami Miami Beach Florida 33140 United States Details
Johns Hopkins Baltimore Maryland 21218 United States Details
Rutgers University New Brunswick New Jersey 08901 United States Details
Mt Sinai New York New York New York 10029 United States Details
Vanderbilt -Ingram Cancer Center Nashville Tennessee 37232 United States Details
University of Utah Salt Lake City Utah 84108 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field